MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s00392-011-0298-z

Медицинская библиотека · Clinical research in cardiology : official journal of the German Cardiac Society · 2011

Successful treatment of thromboangiitis obliterans (Buerger's disease) with immunoadsorption: results of a pilot study.

Baumann Gert, Stangl Verena, Klein-Weigel Peter, Stangl Karl, Laule Michael, Enke-Melzer Kathrin

СтатьяПеревод в очереди

Аннотация

BACKGROUND

No established therapy is available for patients with thromboangiitis obliterans (TAO) and critical limb ischemia. Since abnormalities of the immune system appear to be involved in the pathogenesis, we investigated in this pilot study the efficiency of Ig immunoadsorption (IA) therapy.

METHODS

Ten patients with advanced TAO underwent a single IA course over five consecutive days. Before IA angiography was performed. In addition, the following were conducted prior to IA, directly after, as well as 1, 3, and 6 months after IA: clinical examination, pain scale (0-10), treadmill test for evaluation of maximum walking distances, and several angiological methods for evaluation of disease extent: photoplethysmography, ultrasound Doppler, and transcutaneous assessment of partial carbon dioxide (tcPCO(2)) and oxygen (tcPCO(2)) pressure.

RESULTS

Immunoadsorption treatment was tolerated without side effects. Pain intensity decreased rapidly from 7.7 ± 0.8 (mean ± SEM) before treatment to 2.0 ± 1.2 at the second day of IA. One month after IA, all patients were without pain. This functional amelioration persisted over the follow-up period of 6 months. Correspondingly, maximum walking distances significantly increased from 301.7 ± 191.4 to 727.0 ± 192.7 m immediately after IA, and further continuously up to 1,811.0 ± 223.7 at 6 months after IA. Healing of ischemic ulcerations was observed in all patients during follow-up. (tcPCO(2)) and (tcPCO(2)) values as well as photopletysmographic data that were severely compromised before IA reflecting reduced tissue oxygenation and perfusion showed rapid amelioration reaching normal values at 1 month.

CONCLUSION

Anti-Ig IA appears to be an effective therapeutic option for patients with advanced TAO.

Для цитирования: Baumann Gert, Stangl Verena, Klein-Weigel Peter, Stangl Karl, Laule Michael, Enke-Melzer Kathrin. Successful treatment of thromboangiitis obliterans (Buerger's disease) with immunoadsorption: results of a pilot study.. Clinical research in cardiology : official journal of the German Cardiac Society. 2011. DOI: 10.1007/s00392-011-0298-z.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.